Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Change in Accured Expenses (2018 - 2025)

Dna X filings provide 8 years of Change in Accured Expenses readings, the most recent being -$1.9 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 31.66% to -$1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.0 million, a 124.47% decrease, with the full-year FY2025 number at -$2.0 million, down 124.47% from a year prior.
  • Change in Accured Expenses hit -$1.9 million in Q4 2025 for Dna X, down from $1.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $9.8 million in Q3 2024 to a low of -$2.9 million in Q1 2021.
  • Median Change in Accured Expenses over the past 5 years was $198000.0 (2022), compared with a mean of $347600.0.
  • The widest YoY moves for Change in Accured Expenses: up 1886.42% in 2023, down 778.1% in 2023.
  • Dna X's Change in Accured Expenses stood at -$331000.0 in 2021, then soared by 124.47% to $81000.0 in 2022, then soared by 1886.42% to $1.6 million in 2023, then plummeted by 275.7% to -$2.8 million in 2024, then soared by 31.66% to -$1.9 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$1.9 million (Q4 2025), $1.4 million (Q3 2025), and -$1.2 million (Q2 2025) per Business Quant data.